Acetylsalicylic acid Completed Phase 4 Trials for Coronary Arteriosclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00129038Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
NCT01374698Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.